A long war begins: biosimilars versus patented biologics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A long war begins: biosimilars versus patented biologics

Published:2015-07-27 Issue:12 Volume:18 Page:1071-1073
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Bocquet François¹,Paubel Pascal¹

Affiliation:

1. Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France, Health Law Institute, Inserm, UMR S 1145, Paris Descartes University, Sorbonne Paris Cité, Paris, France, and General Agency of Equipment and Health Products (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Publisher

Informa Healthcare

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.3111/13696998.2015.1075996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?;International Journal of Environmental Research and Public Health;2020-12-29

2. Equitable Access to Biosimilars: An Overview;Equitable Access to High-Cost Pharmaceuticals;2018

3. Drug tendering: drug supply and shortage implications for the uptake of biosimilars;ClinicoEconomics and Outcomes Research;2017-09

4. Inventions and Patents: A Practical Tutorial;Methods in Molecular Biology;2017

5. First monoclonal antibody biosimilars: tackling the challenge of substitution;Journal of Medical Economics;2016-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP